Skip to content
Home/Companies/Biotech/Coultreon Biopharma

Coultreon Biopharma

Biotech·US·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Coultreon Biopharma?

Coultreon Biopharma is currently owned by Novo Holdings through Novo Holdings Seed Investments (1999 vintage), since 2026.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Seed Investments · 1999 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Novo Holdings Seed Investments

Other portfolio companies in the same fund.

cAMPfield
Active
BiotechUS· 2026
QuantumCell
Active
BiotechDenmark· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Orbis Medicines
Active
BiotechDenmark· 2024
RheumaLogics
Active
BiotechDenmark· 2024
Commit Biologics
Active
BiotechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Coultreon Biopharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Coultreon Biopharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Coultreon Biopharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue